Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.11% Nasdaq Down0.42%

Biogen Idec Inc. (BIIB)

-NasdaqGS
303.00 Down 3.20(1.05%) 12:00PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 1,965,850   1,827,780   1,723,473   1,415,096  
Cost of Revenue258,553  234,696  230,728  133,749  
Gross Profit 1,707,297   1,593,084   1,492,745   1,281,347  
Operating Expenses
Research Development422,233  410,017  327,463  284,340  
Selling General and Administrative525,293  405,487  425,849  440,232  
Non Recurring -   -   -   -  
Others109,424  99,998  82,225  51,301  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 657,926   684,531   662,527   510,525  
Income from Continuing Operations
Total Other Income/Expenses Net2,174  2,309  (5,109)(9,406)
Earnings Before Interest And Taxes660,100  686,840  657,418  501,119  
Interest Expense -   -   -   -  
Income Before Tax660,100  686,840  657,418  501,119  
Income Tax Expense190,261  186,105  159,140  65,508  
Minority Interest -   -   -   -  
Net Income From Continuing Ops464,885  494,565  495,989  431,800  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 457,306   487,616   490,670   426,749  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 457,306   487,616   490,670   426,749  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.